Publications
5674 Results
- Journal / Conference
- Cancer Journal from Scientific American 5(4):237-241
- Year
- 1999
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9242
Evaluation of docetaxel in previously untreated extensive stage small cell lung cancer: A Southwest Oncology Group phase II trial.
- Journal / Conference
- Journal of Clinical Oncology 17(7):2173-2179
- Year
- 1999
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8993
High dose melphalan with autotransplantation for refractory multiple myeloma: Results of a Southwest Oncology Group phase II trial.
- Journal / Conference
- Proc of the Society of Gynecologic Oncologists :#1
- Year
- 1999
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8797 (INT-0107) (GOG-109) (RTOG-91-12)
Cisplatin, 5-fluorouracil plus radiation therapy are superior to radiation therapy as adjunctive therapy in high-risk, early-stage carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: Report of a phase III intergroup study.
- Journal / Conference
- Proc of the American Urological Association :#1464
- Year
- 1999
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8507
Maintenance BCG immunotherapy: Evidence of additional protection against cancer. A Southwest Oncology Group study.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 18:333a(#1281)
- Year
- 1999
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9312
Phase II evaluation of cisplatin + 5-fluorouracil + radiation therapy in patients with locally advanced/inoperable bladder cancer. A Southwest Oncology Group study 9312.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 18:467a(#1801)
- Year
- 1999
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8805
Long-term survival after concurrent cisplatin/etoposide (PE) plus chest radiotherapy (RT) followed by surgery in bulky, stages IIIA(N2) and IIIB non-small cell lung cancer (NSCLC): 6-year outcomes from Southwest Oncology Group Study 8805.
- Journal / Conference
- Journal of Clinical Oncology 17(8):2300-2308
- Year
- 1999
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9216 (INT-0131) (NCIC-CTG-BR.8)
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical trials group and the Southwest Oncology Group.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 18:9a(#27)
- Year
- 1999
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-9501
SWOG 95-01: A phase II trial of a combination of fludarabine and mitoxantrone (FN) in untreated advanced low grade lymphoma. An effective, well tolerated therapy.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 18:333a(#1280)
- Year
- 1999
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9457
Carboplatin and paclitaxel (CARBO/TAX) for advanced transitional cell carcinoma (TCC) of the urothelium.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 18:331a(#1275)
- Year
- 1999
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9338